Safety and Efficacy Study of AI Wall Thickness Measurement (EchoNet-LVH-RCT)
EchoNet-LVH-RCT: Blinded, Randomized Controlled Trial of Artificial Intelligence Guided Precision Assessment of Wall Thickness
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: David Ouyang
- Phone Number: 18324951605
- Email: david.ouyang@cshs.org
Study Locations
-
-
California
-
Los Angeles, California, United States, 90048
- Cedars-Sinai Medical Center
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Sonographers and cardiologists at CSMC Echocardiography Lab
- All transthoracic echocardiogram studies performed in the CSMC echocardiogram lab
Exclusion Criteria:
- transthoracic echocardiogram studies not able to be measured by sonographers in run in period
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Sonographer Annotation
Currently, sonographer technicians provide preliminary interpretations prior to validation and overreading by cardiologists.
This staggered, stepwise evaluation allows for the introduction of AI decision support with minimal impact on patient care.
Physicians are already used to adjusting the preliminary report given the variable training of sonographers and on the lookout for changes, variation, or adjustments that need to be made.
|
A sonographer will assess measurements of left ventricular diameter during diastole (LVIDd), intraventricular septum thickness during diastole (IVSd) and left ventricular posterior wall thickness during diastole (LVPWd).
|
|
Experimental: Artificial Intelligence Annotation
A novel AI algorithm developed to assess measurements of left ventricular diameter during diastole (LVIDd), intraventricular septum thickness during diastole (IVSd) and left ventricular posterior wall thickness during diastole (LVPWd).
The AI will provide preliminary assessments for cardiologist evaluation.
|
An AI model will assess measurements of left ventricular diameter during diastole (LVIDd), intraventricular septum thickness during diastole (IVSd) and left ventricular posterior wall thickness during diastole (LVPWd).
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion of studies for which the difference in wall thickness between preliminary to overread is greater than 0.3cm for LVIDd
Time Frame: 10 Minutes
|
Proportion of significant difference in LVIDd between preliminary to final assessment
|
10 Minutes
|
|
Proportion of studies for which the difference in wall thickness between preliminary to overread is greater than 0.2cm for IVSd
Time Frame: 10 Minutes
|
Proportion of significant difference in IVSd between preliminary to final assessment
|
10 Minutes
|
|
Proportion of studies for which the difference in wall thickness between preliminary to overread is greater than 0.2cm for LVPWd
Time Frame: 10 Minutes
|
Proportion of significant difference in LVPWd between preliminary to final assessment
|
10 Minutes
|
|
mean absolute error (MAE) of LVIDd between preliminary to overread between the two arms
Time Frame: 10 Minutes
|
Measurement difference of LVIDd between preliminary to final assessment
|
10 Minutes
|
|
mean absolute error (MAE) of IVSd between preliminary to overread between the two arms
Time Frame: 10 Minutes
|
Measurement difference of IVSd between preliminary to final assessment
|
10 Minutes
|
|
mean absolute error (MAE) of LVPWd between preliminary to overread between the two arms
Time Frame: 10 Minutes
|
Measurement difference of LVPWd between preliminary to final assessment
|
10 Minutes
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
mean absolute error (MAE) of wall thickness between cardiologist overread vs. historical clinical report wall thickness
Time Frame: 10 Minutes
|
Mean absolute error (MAE) of wall thickness between cardiologist overread with initial interpretation vs. prior clinical report wall thickness
|
10 Minutes
|
|
Time to complete each imaging study
Time Frame: 10 Minutes
|
Time for sonographers and cardiologists to complete a study (in seconds)
|
10 Minutes
|
|
Effects of the AI systems integration with computer-human interaction (Blinding)
Time Frame: 10 Minutes
|
Whether cardiologists can tell the difference between human vs. AI initial interpretation (Bang's blinding index, or the proportion of studies guessed correctly to be AI or sonographer compared to ground truth of whether it was AI or sonographer).
|
10 Minutes
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- STUDY00002521
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.